Steven Cohen Chinook Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.66 - $38.58 $11.8 Million - $24.3 Million	-629,770 Reduced 86.01%	102,399 $3.93 Million
Q1 2023 May 15, 2023	SELL	$21.53 - $26.8 $11.5 Million - $14.4 Million	-535,491 Reduced 42.24%	732,169 $16.9 Million
Q4 2022 Feb 14, 2023	SELL	$18.63 - $27.35 $21.9 Million - $32.1 Million	-1,173,094 Reduced 48.06%	1,267,660 $33.2 Million
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $379,179 - $506,077	21,655 Added 0.9%	2,440,754 $48 Million
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $14.7 Million - $21.9 Million	1,164,899 Added 92.88%	2,419,099 $42.3 Million
Q1 2022 May 16, 2022	SELL	$12.02 - $16.69 $13.2 Million - $18.3 Million	-1,097,543 Reduced 46.67%	1,254,200 $20.5 Million
Q4 2021 Feb 14, 2022	BUY	$10.69 - $16.83 $14.5 Million - $22.8 Million	1,356,873 Added 136.39%	2,351,743 $38.4 Million
Q3 2021 Nov 15, 2021	SELL	$11.5 - $14.86 $5.73 Million - $7.4 Million	-498,030 Reduced 33.36%	994,870 $12.7 Million
Q2 2021 Aug 16, 2021	BUY	$13.6 - $18.98 $4.39 Million - $6.12 Million	322,702 Added 27.58%	1,492,900 $21.1 Million
Q1 2021 May 17, 2021	BUY	$14.17 - $19.11 $3.87 Million - $5.22 Million	272,952 Added 30.42%	1,170,198 $18.2 Million
Q4 2020 Feb 16, 2021	BUY	$11.9 - $20.91 $10.7 Million - $18.8 Million	897,246 New	897,246 $14.2 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.